6F2C image
Deposition Date 2017-11-24
Release Date 2018-03-07
Last Version Date 2024-01-17
Entry Detail
PDB ID:
6F2C
Keywords:
Title:
Methylglyoxal synthase MgsA from Bacillus subtilis
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.34 Å
R-Value Free:
0.20
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Methylglyoxal synthase
Gene (Uniprot):mgsA
Chain IDs:A, B (auth: D), C (auth: B), D (auth: F), E (auth: C), F (auth: E), G (auth: H), H (auth: K), I (auth: G), J (auth: I), K (auth: L), L (auth: J)
Chain Length:160
Number of Molecules:12
Biological Source:Bacillus subtilis (strain 168)
Primary Citation
Structural basis for the regulatory interaction of the methylglyoxal synthase MgsA with the carbon flux regulator Crh inBacillus subtilis.
J. Biol. Chem. 293 5781 5792 (2018)
PMID: 29514981 DOI: 10.1074/jbc.RA117.001289

Abstact

Utilization of energy-rich carbon sources such as glucose is fundamental to the evolutionary success of bacteria. Glucose can be catabolized via glycolysis for feeding the intermediary metabolism. The methylglyoxal synthase MgsA produces methylglyoxal from the glycolytic intermediate dihydroxyacetone phosphate. Methylglyoxal is toxic, requiring stringent regulation of MgsA activity. In the Gram-positive bacterium Bacillus subtilis, an interaction with the phosphoprotein Crh controls MgsA activity. In the absence of preferred carbon sources, Crh is present in the nonphosphorylated state and binds to and thereby inhibits MgsA. To better understand the mechanism of regulation of MgsA, here we performed biochemical and structural analyses of B. subtilis MgsA and of its interaction with Crh. Our results indicated that MgsA forms a hexamer (i.e. a trimer of dimers) in the crystal structure, whereas it seems to exist in an equilibrium between a dimer and hexamer in solution. In the hexamer, two alternative dimers could be distinguished, but only one appeared to prevail in solution. Further analysis strongly suggested that the hexamer is the biologically active form. In vitro cross-linking studies revealed that Crh interacts with the N-terminal helices of MgsA and that the Crh-MgsA binding inactivates MgsA by distorting and thereby blocking its active site. In summary, our results indicate that dimeric and hexameric MgsA species exist in an equilibrium in solution, that the hexameric species is the active form, and that binding to Crh deforms and blocks the active site in MgsA.

Legend

Protein

Chemical

Disease

Primary Citation of related structures